Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Jacqueline Montes1, Sally Dunaway Young1, Elena Mazzone2

  • 1Departments of Rehabilitation and Regenerative Medicine and Neurology, Columbia University Medical Center, New York, NY, USA.

Neuromuscular Disorders : NMD
|September 18, 2017
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial.

Nature medicine·2026
Same author

Navigating new motor function trajectories: Consensus recommendations for assessment in the era of newborn screening and early treatment in SMA.

Journal of neuromuscular diseases·2026
Same author

High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial.

Nature medicine·2026
Same author

Loss of ambulation in SMA III at the time of disease-modifying treatments: an international study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

A plain language summary of the SAPPHIRE clinical trial of apitegromab in children and young adults with spinal muscular atrophy.

Expert review of neurotherapeutics·2025
Same author

Differences in swallowing efficacy of disease modifying treatment between infants receiving pre-symptomatic and symptomatic administration.

Orphanet journal of rare diseases·2025